Outcomes of Full Pulpotomy Treatment in Teeth With Symptoms of Irreversible Pulpitis

Last updated: September 20, 2025
Sponsor: Firat University
Overall Status: Active - Not Recruiting

Phase

4

Condition

Acute And Chronic Dental Pain

Treatment

NeoPutty (calcium silicate-based cement) (Avalon Biomed, Bradenton, USA)

Biodentine (calcium silicate-based cement) (Septodont, Saint Maur de Fossés, France)

Clinical Study ID

NCT06802536
FIRATUNI-DENTISTRY-TUBAGOK-001
  • Ages 18-50
  • All Genders

Study Summary

The aim of this clinical trial is to learn how successful Biodentine and NeoPutty dental filling materials are in treating dental pulp inflammation in adults. It will also provide information about post-treatment pain. The main questions it aims to answer are:

Do Biodentine and NeoPutty dental filling materials treat dental pulpitis in participants? Do they reduce the need for root canal treatment?

After the application of Biodentine and NeoPutty dental filling materials to the participants, the pain and symptoms that cause pain may not decrease. In this case, the tooth may be treated with root canal treatment.

The researchers will compare the clinical success of Biodentine and NeoPutty dental filling materials with each other.

Participants will undergo a single-session pulpotomy treatment with the dental filling materials mentioned above. Clinical and radiographic follow-ups will then be performed at 3, 6 and 12 months, and records will be kept.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • • Patient age must be between 18-50 years

  • Must be able to give written informed consent

  • Must have systemic status (ASA 1)

  • Must have mature permanent molar or premolar (lower upper)

  • Must be symptomatic (spontaneous pain - mild to severe), extremely deep (D4)carious teeth

  • Must have pulp exposure in non-selective carious cleaning procedure

  • Must have vital response in cold test and electric pulp test

  • Must have no periodontal disease

  • Must have restorable teeth

  • Must have teeth without pulp necrosis, sinus tract or swelling/abscess

  • Must have bleeding time less than 10 minutes

  • Maximum two teeth in a patient must be included in the study (must be indifferent quadrants and must have at least 2 weeks between treatment periods)

Exclusion

Exclusion Criteria:

  • Teeth with incomplete root development

  • Teeth without symptoms of irreversible pulpitis

  • Severely affected teeth that do not respond to pulp sensitivity tests

  • Teeth without signs of bleeding after exposure with the pulp chamber

  • Teeth with pulp chamber open to the oral environment

  • Teeth with periodontal pockets greater than 4 mm deep

  • Teeth with suspected cracks or crown fractures that may be responsible for pulppathology

  • Teeth with uncontrolled bleeding

  • Medically risky patients will be excluded from the study.

Study Design

Total Participants: 60
Treatment Group(s): 2
Primary Treatment: NeoPutty (calcium silicate-based cement) (Avalon Biomed, Bradenton, USA)
Phase: 4
Study Start date:
April 15, 2024
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • Firat University

    Elazığ, 23119
    Turkey

    Site Not Available

  • Firat University

    Elâzığ 315808, 23119
    Turkey (Türkiye)

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.